Koers Teva Pharmaceutical Industries Limited TEL AVIV STOCK EXCHANGE
Aandelen
IL0006290147
Farmaceutische producten
Omzet 2024 * | 15,86 mld. 6.039 mld. 14,84 mld. | Omzet 2025 * | 16,35 mld. 6.223 mld. 15,29 mld. | Marktkapitalisatie | 15,64 mld. 5.955 mld. 14,63 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 1,54 mld. 586 mld. 1,44 mld. | Nettowinst (verlies) 2025 * | 1,44 mld. 549 mld. 1,35 mld. | EV/omzet 2024 * | 1,91 x |
Nettoschuld 2024 * | 14,62 mld. 5.567 mld. 13,68 mld. | Nettoschuld 2025 * | 12,12 mld. 4.613 mld. 11,33 mld. | EV/omzet 2025 * | 1,7 x |
K/w-verhouding 2024 * |
11,1
x | K/w-verhouding 2025 * |
10,3
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 89,71% |
Recentste transcriptie over Teva Pharmaceutical Industries Limited
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Richard Francis
CEO | Chief Executive Officer | 55 | 01-01-23 |
Eli Kalif
DFI | Director of Finance/CFO | 51 | 22-12-19 |
Eric Hughes
CTO | Chief Tech/Sci/R&D Officer | - | 01-08-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Gerald Lieberman
BRD | Director/Board Member | 77 | 01-09-15 |
Janet Vergis
BRD | Director/Board Member | 60 | 09-06-20 |
Sol Barer
CHM | Chairman | 76 | 01-01-15 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+25,83% | 661 mld. | |
+27,00% | 566 mld. | |
-6,76% | 352 mld. | |
+20,34% | 332 mld. | |
+3,00% | 283 mld. | |
+13,09% | 231 mld. | |
+5,46% | 200 mld. | |
-9,61% | 195 mld. | |
-6,26% | 145 mld. |